002737: Sunflower Pharmaceutical Group Co.,Ltd - Summary | Jitta

Sunflower Pharmaceutical Group Co.,Ltd

CHN:002737

Price
CN¥13.88
Loss Chance
50.8%
3.26JITTA SCORE
> 1,000%Over Jitta Line
Jitta Ranking
272 / 487
2,581 / 5,259
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (29)
Recent Business Performance (31)
Financial Strength (64)
Return to Shareholders (30)
Competitive Advantage (37)
Jitta Signs
Debt LevelLow Long Term Debt
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 141.82% in the last year
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
3.26
> 1,000%
4.42
> 1,000%
4.24
> 1,000%
Pharmaceuticals
6.36
2.64%
5.47
25.22%
7.76
43.10%
COMPANY DESCRIPTION
Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. The company produces chemical and biological medicines, and health care products. It also provides products covering various therapeutic areas, including pediatrics, gynecology, adult digestive system, respiratory and cold, rheumatic bone disease, and cardiovascular and cerebrovascular; supplements; tonic; and antibiotics and children’s medicinal products. The company sells its products under the Sunflower and Little Sunflower brands. Sunflower Pharmaceutical Group Co.,Ltd was founded in 2005 and is based in Harbin, China.